Agency Forms Undergoing Paperwork Reduction Act Review, 51823 [E7-17837]
Download as PDF
<![CDATA[
51823
Federal Register / Vol. 72, No. 175 / Tuesday, September 11, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–07–0398x]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
Evaluation of an Intervention to
Increase Colorectal Cancer Screening in
Primary Care Clinics-New-National
Center for Chronic Disease Prevention
and Health Promotion (NCDDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Colorectal cancer (CRC) is the third
most frequent form of cancer and the
second leading cause of cancer-related
average-risk patients aged 50–80 years,
clinicians, and clinic support staff
within the primary care clinics in two
managed care organizations (MCOs).
There are three tasks in this study. In
Task 1, 140 primary care clinicians will
complete a survey assessing
demographics, opinions about
preventive services, CRC screening
training and practices, satisfaction with
CRC screening, and CRC screening
beliefs, facilitators, and barriers. The
survey will be administered to primary
care clinicians post-intervention. In
Task 2, 140 clinic support staff will
complete a survey assessing
demographics, work-related
responsibilities, opinions about
preventive services, CRC training and
practices, satisfaction with CRC
screening, and CRC screening beliefs,
facilitators and barriers. The survey will
be administered to clinic support staff
post intervention. In Task 3, clinic
patients will complete a survey
assessing demographics, health status,
receipt of previous CRC screening and
other preventive services, knowledge
and opinions about CRC and CRC
screening, and social support. The
survey will be administered to 3307
patients pre-intervention and 3307
patients post-intervention.
There will be no cost to respondents
other than their time. The total
estimated annualized burden hours are
2352.
deaths among both men and women in
the United States. Research shows that
screening can reduce both the
occurrence of colorectal cancer and
colorectal cancer deaths. Screening is
beneficial for: (1) Detection and removal
of precancerous polyps, resulting in
patients recovering without progression
to a diagnosis of cancer, and (2) early
detection of CRC for more effective
treatment and improved survival.
Regular CRC screening is recommended
for people aged 50 years and older.
Many screening tests are widely
available and screening has been shown
to be effective in reducing CRC
mortality. Despite this demonstrated
effectiveness, CRC screening remains
low. Some reasons attributed to the low
screening rates include limited public
awareness of CRC and the benefits of
screening, failure of health care
providers to recommend screening to
patients, and inefficient surveillance
and support systems in many health
care settings.
The purpose of this study is to
evaluate and understand the effect of a
multi-component intervention on CRC
screening rates in primary care clinics.
The study will also examine the effects
of the intervention conditions on
behavioral outcomes (e.g., clinicianpatient discussions about CRC
screening) and on attitudes, beliefs,
opinions, and social influence
surrounding CRC screening among
patients. The target population includes
ESTIMATE OF ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Clinicians ......................................................................................................................................
Clinic Support Staff ......................................................................................................................
Patients surveyed only at baseline ..............................................................................................
Patients surveyed at baseline and follow-up ...............................................................................
Patients surveyed only at follow-up .............................................................................................
Dated: September 5, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–17837 Filed 9–10–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
National Mammography Quality
Assurance Advisory Committee;
Notice of Meeting
sroberts on PROD1PC70 with NOTICES
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
VerDate Aug<31>2005
17:06 Sep 10, 2007
Jkt 211001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
140
140
2335
972
2335
Number of
responses per
respondent
1
1
1
2
1
Average
burden per
response
(in hours)
30/60
25/60
20/60
20/60
20/60
(FDA). The meeting will be open to the
public.
Name of Committee: National
Mammography Quality Assurance
Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on November 5, 2007, from 9 a.m.
to 5 p.m.
Location: Crown Plaza Rockville,
Remington II and III in the Ballroom, 3
Research Ct., Rockville, MD.
E:\FR\FM\11SEN1.SGM
11SEN1
]]>Agencies
[Federal Register Volume 72, Number 175 (Tuesday, September 11, 2007)]
[Notices]
[Page 51823]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-17837]
[[Page 51823]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-07-0398x]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Evaluation of an Intervention to Increase Colorectal Cancer
Screening in Primary Care Clinics-New-National Center for Chronic
Disease Prevention and Health Promotion (NCDDPHP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Colorectal cancer (CRC) is the third most frequent form of cancer
and the second leading cause of cancer-related deaths among both men
and women in the United States. Research shows that screening can
reduce both the occurrence of colorectal cancer and colorectal cancer
deaths. Screening is beneficial for: (1) Detection and removal of
precancerous polyps, resulting in patients recovering without
progression to a diagnosis of cancer, and (2) early detection of CRC
for more effective treatment and improved survival. Regular CRC
screening is recommended for people aged 50 years and older. Many
screening tests are widely available and screening has been shown to be
effective in reducing CRC mortality. Despite this demonstrated
effectiveness, CRC screening remains low. Some reasons attributed to
the low screening rates include limited public awareness of CRC and the
benefits of screening, failure of health care providers to recommend
screening to patients, and inefficient surveillance and support systems
in many health care settings.
The purpose of this study is to evaluate and understand the effect
of a multi-component intervention on CRC screening rates in primary
care clinics. The study will also examine the effects of the
intervention conditions on behavioral outcomes (e.g., clinician-patient
discussions about CRC screening) and on attitudes, beliefs, opinions,
and social influence surrounding CRC screening among patients. The
target population includes average-risk patients aged 50-80 years,
clinicians, and clinic support staff within the primary care clinics in
two managed care organizations (MCOs). There are three tasks in this
study. In Task 1, 140 primary care clinicians will complete a survey
assessing demographics, opinions about preventive services, CRC
screening training and practices, satisfaction with CRC screening, and
CRC screening beliefs, facilitators, and barriers. The survey will be
administered to primary care clinicians post-intervention. In Task 2,
140 clinic support staff will complete a survey assessing demographics,
work-related responsibilities, opinions about preventive services, CRC
training and practices, satisfaction with CRC screening, and CRC
screening beliefs, facilitators and barriers. The survey will be
administered to clinic support staff post intervention. In Task 3,
clinic patients will complete a survey assessing demographics, health
status, receipt of previous CRC screening and other preventive
services, knowledge and opinions about CRC and CRC screening, and
social support. The survey will be administered to 3307 patients pre-
intervention and 3307 patients post-intervention.
There will be no cost to respondents other than their time. The
total estimated annualized burden hours are 2352.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Clinicians...................................................... 140 1 30/60
Clinic Support Staff............................................ 140 1 25/60
Patients surveyed only at baseline.............................. 2335 1 20/60
Patients surveyed at baseline and follow-up..................... 972 2 20/60
Patients surveyed only at follow-up............................. 2335 1 20/60
----------------------------------------------------------------------------------------------------------------
Dated: September 5, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E7-17837 Filed 9-10-07; 8:45 am]
BILLING CODE 4163-18-P
